bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.05.657989

Data-driven identification of biomedical systems using multi-scale analysis

Abstract

Biomedical systems inherently exhibit multi-scale dynamics, making accurate system identification particularly challenging due to the complexity of capturing a wide time scale spectrum. Traditional methods capable of addressing this issue rely on explicit equations, limiting their applicability in cases where only observational data are available. To overcome this limitation, we propose a data-driven framework that integrates the Sparse Identification of Nonlinear Dynamics (SINDy) method, the multi scale analysis algorithm Computational Singular Perturbation (CSP) and neural networks (NNs). This framework allows the partition of the available dataset in subsets characterized by similar dynamics, so that system identification can proceed within these subsets without facing a wide time scale spectrum. Accordingly, when the full dataset does not allow SINDy to identify the proper model, CSP is employed for the generation of subsets of similar dynamics, which are then fed into SINDy. CSP requires the availability of the gradient of the vector field, which is estimated by the NNs. The framework is tested on the Michaelis-Menten model, for which various reduced models in analytic form exist at different parts of the phase space. It is demonstrated that the CSP-based data subsets allow SINDy to identify the proper reduced model in cases where the full dataset does not. In addition, it is demonstrated that the framework succeeds even in the cases where the available data set originates from stochastic versions of the Michaelis-Menten model. This framework is algorithmic, so system identification is not hindered by the dimensions of the dataset. Author summaryBiomedical systems often evolve across multiple time scales, posing major challenges for constructing accurate models directly from data. Traditional model reduction techniques require explicit equations and thus cannot be applied when only observational data are available. To address this, we developed a data-driven framework that combines Sparse Identification of Nonlinear Dynamics (SINDy), Computational Singular Perturbation (CSP) and neural networks (NNs). Our approach automatically partitions a dataset into subsets characterized by similar dynamics, allowing valid reduced models to be identified in each region. When SINDy fails to recover a global model from the full dataset, CSP -leveraging Jacobian estimates from NNs-successfully isolates dynamical regimes where SINDy can be applied locally. We validated this framework using the Michaelis-Menten biochemical model, which is known to admit multiple reduced models in different regions of the phase space. Our method consistently identified the appropriate reduced dynamics, even when the data originated from stochastic simulations. Because our approach is algorithmic and equation-free, it is scalable to high-dimensional systems and robust to noise, offering a promising solution for data-driven model discovery in complex biomedical systems.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Muhammed, I., Manias, D. M., Goussis, D. A., Hatzikirou, H.. 2025-06-09. Data-driven identification of biomedical systems using multi-scale analysis. https://doi.org/10.1101/2025.06.05.657989

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗